ArcticZymes Technologies
1 investor følger denne virksomhed
ArcticZymes Technologies is a biotechnology company. The company specializes in the research and development of pharmaceuticals for the treatment of immune diseases. The main focus is on the development of glucans, the development of immune-stimulating agents, and the analysis of enzymes. The vision is to test and develop the medicine and then pass these on in use for RNA and DNA processes. ArcticZymes Technologies previously went by the name Biotec Pharmacon and is headquartered in Tromsö.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
Oslo Børs
AZT
Daglig lav / høj pris
-
Markedsværdi
-
Aktieomsætning
-
Volumen
-
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Skandinaviska Enskilda Banken AB | 13,2 % | 13,2 % |
| Skandinaviska Enskilda Banken AB 2 | 7,4 % | 7,4 % |
Premium
Not activated
This content is for our Premium customers only.
ViserAlle indholdstyper